Stocks
Blueprint Medicines Corporation (BPMC) R&D US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 326.9 | 601.0 | 477.4 | 427.7 | 341.4 | 341.5 | |||
| Changes by years, y/y, % | -1% | +84% | -21% | -10% | -20% | +0.6% | |||
Blueprint Medicines Corporation. R&D, bln rub
Blueprint Medicines Corporation. R&D, changes, %
Blueprint Medicines Corporation. R&D, sum by quarters, bln rub
Blueprint Medicines Corporation (BPMC) R&D US GAAP (quarter values) |
||||||||
| FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| R&D, bln rub | 83.4 | 80.7 | 85.3 | 83.7 | 91.9 | 341.5 | ||
| Changes by years, y/y, % | -26% | -27% | -23% | -13% | +10% | |||
| Changes by quarters, q/q, % | -13% | -3% | +6% | -2% | +10% | |||
